Signal Transduction and Targeted Therapy (Feb 2022)
Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
Abstract
No abstracts available.